APO Research
Talk to an analyst

APO RESEARCH · REPORT

PECAM-1 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global PECAM-1 Antibody Market Analysis and Forecast 2026-2032

31 December 2025218 pages

Choose your research edition.

Industry ResearchPECAM-1 Antibody Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal PECAM-1 Antibody Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal PECAM-1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PECAM-1 Antibody Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal PECAM-1 Antibody Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global PECAM-1 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for PECAM-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for PECAM-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for PECAM-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for PECAM-1 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of PECAM-1 Antibody include Thermo Fisher, YO Proteins, US Biological, SICGEN, Santa Cruz Biotechnology, Rockland Immunochemicals, R&D Systems, Proteintech Group and OriGene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for PECAM-1 Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of PECAM-1 Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for PECAM-1 Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PECAM-1 Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global PECAM-1 Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for PECAM-1 Antibody sales, projected growth trends, production technology, application and end-user industry.

PECAM-1 Antibody Segment by Company

Thermo Fisher

YO Proteins

US Biological

SICGEN

Santa Cruz Biotechnology

Rockland Immunochemicals

R&D Systems

Proteintech Group

OriGene

Novus Biologicals

Miltenyi Biotec

MilliporeSigma

LifeSpan Biosciences

Enzo Life Sciences

Dianova

Creative Biomart

Boster

Bon Opus Biosciences

Bio-Rad

BioLegend

Abnova

Abeomics

Abcam

PECAM-1 Antibody Segment by Type

Mouse

Rabbit

Others

PECAM-1 Antibody Segment by Application

Laboratory

Hospital

Others

PECAM-1 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PECAM-1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PECAM-1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PECAM-1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of PECAM-1 Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of PECAM-1 Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PECAM-1 Antibody sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global PECAM-1 Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Mouse Major Manufacturers Table 3. Rabbit Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global PECAM-1 Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Laboratory Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Others Major Manufacturers Table 9. PECAM-1 Antibody Industry Trends Table 10. PECAM-1 Antibody Industry Drivers Table 11. PECAM-1 Antibody Industry Opportunities and Challenges Table 12. PECAM-1 Antibody Industry Restraints Table 13. Global PECAM-1 Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global PECAM-1 Antibody Revenue by Region (2021-2026) & (US$ Million) Table 15. Global PECAM-1 Antibody Revenue by Region (2027-2032) & (US$ Million) Table 16. Global PECAM-1 Antibody Revenue Market Share by Region (2021-2026) Table 17. Global PECAM-1 Antibody Revenue Market Share by Region (2027-2032) Table 18. Global PECAM-1 Antibody Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 19. Global PECAM-1 Antibody Sales by Region (2021-2026) & (Kg) Table 20. Global PECAM-1 Antibody Sales by Region (2027-2032) & (Kg) Table 21. Global PECAM-1 Antibody Sales Market Share by Region (2021-2026) Table 22. Global PECAM-1 Antibody Sales Market Share by Region (2027-2032) Table 23. Global PECAM-1 Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global PECAM-1 Antibody Revenue Market Share by Manufacturers (2021-2026) Table 25. Global PECAM-1 Antibody Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global PECAM-1 Antibody Sales Market Share by Manufacturers (2021-2026) Table 27. Global PECAM-1 Antibody Sales Price (US$/g) of Manufacturers (2021-2026) Table 28. Global PECAM-1 Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global PECAM-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global PECAM-1 Antibody Manufacturers, Product Type & Application Table 31. Global PECAM-1 Antibody Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global PECAM-1 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global PECAM-1 Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global PECAM-1 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 36. Global PECAM-1 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 37. Global PECAM-1 Antibody Revenue Market Share by Type (2021-2026) Table 38. Global PECAM-1 Antibody Revenue Market Share by Type (2027-2032) Table 39. Global PECAM-1 Antibody Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 40. Global PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 41. Global PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 42. Global PECAM-1 Antibody Sales Market Share by Type (2021-2026) Table 43. Global PECAM-1 Antibody Sales Market Share by Type (2027-2032) Table 44. Global PECAM-1 Antibody Price by Type (2021-2026) & (US$/g) Table 45. Global PECAM-1 Antibody Price by Type (2027-2032) & (US$/g) Table 46. Global PECAM-1 Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global PECAM-1 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 48. Global PECAM-1 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 49. Global PECAM-1 Antibody Revenue Market Share by Application (2021-2026) Table 50. Global PECAM-1 Antibody Revenue Market Share by Application (2027-2032) Table 51. Global PECAM-1 Antibody Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 52. Global PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 53. Global PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 54. Global PECAM-1 Antibody Sales Market Share by Application (2021-2026) Table 55. Global PECAM-1 Antibody Sales Market Share by Application (2027-2032) Table 56. Global PECAM-1 Antibody Price by Application (2021-2026) & (US$/g) Table 57. Global PECAM-1 Antibody Price by Application (2027-2032) & (US$/g) Table 58. Thermo Fisher Company Information Table 59. Thermo Fisher Business Overview Table 60. Thermo Fisher PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 61. Thermo Fisher PECAM-1 Antibody Product Portfolio Table 62. Thermo Fisher Recent Development Table 63. YO Proteins Company Information Table 64. YO Proteins Business Overview Table 65. YO Proteins PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. YO Proteins PECAM-1 Antibody Product Portfolio Table 67. YO Proteins Recent Development Table 68. US Biological Company Information Table 69. US Biological Business Overview Table 70. US Biological PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. US Biological PECAM-1 Antibody Product Portfolio Table 72. US Biological Recent Development Table 73. SICGEN Company Information Table 74. SICGEN Business Overview Table 75. SICGEN PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. SICGEN PECAM-1 Antibody Product Portfolio Table 77. SICGEN Recent Development Table 78. Santa Cruz Biotechnology Company Information Table 79. Santa Cruz Biotechnology Business Overview Table 80. Santa Cruz Biotechnology PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Santa Cruz Biotechnology PECAM-1 Antibody Product Portfolio Table 82. Santa Cruz Biotechnology Recent Development Table 83. Rockland Immunochemicals Company Information Table 84. Rockland Immunochemicals Business Overview Table 85. Rockland Immunochemicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Rockland Immunochemicals PECAM-1 Antibody Product Portfolio Table 87. Rockland Immunochemicals Recent Development Table 88. R&D Systems Company Information Table 89. R&D Systems Business Overview Table 90. R&D Systems PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. R&D Systems PECAM-1 Antibody Product Portfolio Table 92. R&D Systems Recent Development Table 93. Proteintech Group Company Information Table 94. Proteintech Group Business Overview Table 95. Proteintech Group PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. Proteintech Group PECAM-1 Antibody Product Portfolio Table 97. Proteintech Group Recent Development Table 98. OriGene Company Information Table 99. OriGene Business Overview Table 100. OriGene PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. OriGene PECAM-1 Antibody Product Portfolio Table 102. OriGene Recent Development Table 103. Novus Biologicals Company Information Table 104. Novus Biologicals Business Overview Table 105. Novus Biologicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. Novus Biologicals PECAM-1 Antibody Product Portfolio Table 107. Novus Biologicals Recent Development Table 108. Miltenyi Biotec Company Information Table 109. Miltenyi Biotec Business Overview Table 110. Miltenyi Biotec PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Miltenyi Biotec PECAM-1 Antibody Product Portfolio Table 112. Miltenyi Biotec Recent Development Table 113. MilliporeSigma Company Information Table 114. MilliporeSigma Business Overview Table 115. MilliporeSigma PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 116. MilliporeSigma PECAM-1 Antibody Product Portfolio Table 117. MilliporeSigma Recent Development Table 118. LifeSpan Biosciences Company Information Table 119. LifeSpan Biosciences Business Overview Table 120. LifeSpan Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 121. LifeSpan Biosciences PECAM-1 Antibody Product Portfolio Table 122. LifeSpan Biosciences Recent Development Table 123. Enzo Life Sciences Company Information Table 124. Enzo Life Sciences Business Overview Table 125. Enzo Life Sciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 126. Enzo Life Sciences PECAM-1 Antibody Product Portfolio Table 127. Enzo Life Sciences Recent Development Table 128. Dianova Company Information Table 129. Dianova Business Overview Table 130. Dianova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 131. Dianova PECAM-1 Antibody Product Portfolio Table 132. Dianova Recent Development Table 133. Creative Biomart Company Information Table 134. Creative Biomart Business Overview Table 135. Creative Biomart PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 136. Creative Biomart PECAM-1 Antibody Product Portfolio Table 137. Creative Biomart Recent Development Table 138. Boster Company Information Table 139. Boster Business Overview Table 140. Boster PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 141. Boster PECAM-1 Antibody Product Portfolio Table 142. Boster Recent Development Table 143. Bon Opus Biosciences Company Information Table 144. Bon Opus Biosciences Business Overview Table 145. Bon Opus Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 146. Bon Opus Biosciences PECAM-1 Antibody Product Portfolio Table 147. Bon Opus Biosciences Recent Development Table 148. Bio-Rad Company Information Table 149. Bio-Rad Business Overview Table 150. Bio-Rad PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 151. Bio-Rad PECAM-1 Antibody Product Portfolio Table 152. Bio-Rad Recent Development Table 153. BioLegend Company Information Table 154. BioLegend Business Overview Table 155. BioLegend PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 156. BioLegend PECAM-1 Antibody Product Portfolio Table 157. BioLegend Recent Development Table 158. Abnova Company Information Table 159. Abnova Business Overview Table 160. Abnova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 161. Abnova PECAM-1 Antibody Product Portfolio Table 162. Abnova Recent Development Table 163. Abeomics Company Information Table 164. Abeomics Business Overview Table 165. Abeomics PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 166. Abeomics PECAM-1 Antibody Product Portfolio Table 167. Abeomics Recent Development Table 168. Abcam Company Information Table 169. Abcam Business Overview Table 170. Abcam PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 171. Abcam PECAM-1 Antibody Product Portfolio Table 172. Abcam Recent Development Table 173. North America PECAM-1 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 174. North America PECAM-1 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 175. North America PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 176. North America PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 177. North America PECAM-1 Antibody Sales Price by Type (2021-2026) & (US$/g) Table 178. North America PECAM-1 Antibody Sales Price by Type (2027-2032) & (US$/g) Table 179. North America PECAM-1 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 180. North America PECAM-1 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 181. North America PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 182. North America PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 183. North America PECAM-1 Antibody Sales Price by Application (2021-2026) & (US$/g) Table 184. North America PECAM-1 Antibody Sales Price by Application (2027-2032) & (US$/g) Table 185. North America PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. North America PECAM-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. North America PECAM-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. North America PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 189. North America PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 190. North America PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 191. North America PECAM-1 Antibody Sales Price by Country (2021-2026) & (US$/g) Table 192. North America PECAM-1 Antibody Sales Price by Country (2027-2032) & (US$/g) Table 193. United States PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 194. Canada PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 195. Europe PECAM-1 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 196. Europe PECAM-1 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 197. Europe PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 198. Europe PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 199. Europe PECAM-1 Antibody Sales Price by Type (2021-2026) & (US$/g) Table 200. Europe PECAM-1 Antibody Sales Price by Type (2027-2032) & (US$/g) Table 201. Europe PECAM-1 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 202. Europe PECAM-1 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 203. Europe PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 204. Europe PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 205. Europe PECAM-1 Antibody Sales Price by Application (2021-2026) & (US$/g) Table 206. Europe PECAM-1 Antibody Sales Price by Application (2027-2032) & (US$/g) Table 207. Europe PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Europe PECAM-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Europe PECAM-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Europe PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 211. Europe PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 212. Europe PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 213. Europe PECAM-1 Antibody Sales Price by Country (2021-2026) & (US$/g) Table 214. Europe PECAM-1 Antibody Sales Price by Country (2027-2032) & (US$/g) Table 215. Germany PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 216. France PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 217. U.K. PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 218. Italy PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 219. Netherlands PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 220. China PECAM-1 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 221. China PECAM-1 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 222. China PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 223. China PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 224. China PECAM-1 Antibody Sales Price by Type (2021-2026) & (US$/g) Table 225. China PECAM-1 Antibody Sales Price by Type (2027-2032) & (US$/g) Table 226. China PECAM-1 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 227. China PECAM-1 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 228. China PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 229. China PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 230. China PECAM-1 Antibody Sales Price by Application (2021-2026) & (US$/g) Table 231. China PECAM-1 Antibody Sales Price by Application (2027-2032) & (US$/g) Table 232. Asia PECAM-1 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 233. Asia PECAM-1 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 234. Asia PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 235. Asia PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 236. Asia PECAM-1 Antibody Sales Price by Type (2021-2026) & (US$/g) Table 237. Asia PECAM-1 Antibody Sales Price by Type (2027-2032) & (US$/g) Table 238. Asia PECAM-1 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 239. Asia PECAM-1 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 240. Asia PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 241. Asia PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 242. Asia PECAM-1 Antibody Sales Price by Application (2021-2026) & (US$/g) Table 243. Asia PECAM-1 Antibody Sales Price by Application (2027-2032) & (US$/g) Table 244. Asia PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. Asia PECAM-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. Asia PECAM-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. Asia PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 248. Asia PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 249. Asia PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 250. Asia PECAM-1 Antibody Sales Price by Country (2021-2026) & (US$/g) Table 251. Asia PECAM-1 Antibody Sales Price by Country (2027-2032) & (US$/g) Table 252. Japan PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 253. South Korea PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 254. India PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 255. Australia PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 256. China Taiwan PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 257. Southeast Asia PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 258. SAMEA PECAM-1 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 259. SAMEA PECAM-1 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 260. SAMEA PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 261. SAMEA PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 262. SAMEA PECAM-1 Antibody Sales Price by Type (2021-2026) & (US$/g) Table 263. SAMEA PECAM-1 Antibody Sales Price by Type (2027-2032) & (US$/g) Table 264. SAMEA PECAM-1 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 265. SAMEA PECAM-1 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 266. SAMEA PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 267. SAMEA PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 268. SAMEA PECAM-1 Antibody Sales Price by Application (2021-2026) & (US$/g) Table 269. SAMEA PECAM-1 Antibody Sales Price by Application (2027-2032) & (US$/g) Table 270. SAMEA PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 271. SAMEA PECAM-1 Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 272. SAMEA PECAM-1 Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 273. SAMEA PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 274. SAMEA PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 275. SAMEA PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 276. SAMEA PECAM-1 Antibody Sales Price by Country (2021-2026) & (US$/g) Table 277. SAMEA PECAM-1 Antibody Sales Price by Country (2027-2032) & (US$/g) Table 278. Brazil PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 279. Argentina PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 280. Chile PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 281. Colombia PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 282. Peru PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 283. Saudi Arabia PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 284. Israel PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 285. UAE PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 286. Turkey PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 287. Iran PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 288. Egypt PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Table 289. Key Raw Materials Table 290. Raw Materials Key Suppliers Table 291. PECAM-1 Antibody Distributors List Table 292. PECAM-1 Antibody Customers List Table 293. Research Programs/Design for This Report Table 294. Authors List of This Report Table 295. Secondary Sources Table 296. Primary Sources List of Figures Figure 1. PECAM-1 Antibody Image Figure 2. Global PECAM-1 Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PECAM-1 Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Mouse Image Figure 5. Rabbit Image Figure 6. Others Image Figure 7. Global PECAM-1 Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global PECAM-1 Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 9. Laboratory Image Figure 10. Hospital Image Figure 11. Others Image Figure 12. Global PECAM-1 Antibody Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global PECAM-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 14. Global PECAM-1 Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global PECAM-1 Antibody Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global PECAM-1 Antibody Revenue Market Share by Region (2021-2032) Figure 17. Global PECAM-1 Antibody Sales (2021-2032) & (Kg) Figure 18. Global PECAM-1 Antibody Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 19. Global PECAM-1 Antibody Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico PECAM-1 Antibody Sales YoY (2021-2032) & (Kg) Figure 21. Europe PECAM-1 Antibody Sales YoY (2021-2032) & (Kg) Figure 22. China PECAM-1 Antibody Sales YoY (2021-2032) & (Kg) Figure 23. Asia (Excluding China) PECAM-1 Antibody Sales YoY (2021-2032) & (Kg) Figure 24. South America, Middle East and Africa PECAM-1 Antibody Sales YoY (2021-2032) & (Kg) Figure 25. Global PECAM-1 Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global PECAM-1 Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global PECAM-1 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global PECAM-1 Antibody Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global PECAM-1 Antibody Revenue Market Share by Type (2021-2032) Figure 31. Global PECAM-1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 32. Global PECAM-1 Antibody Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global PECAM-1 Antibody Sales Market Share by Type (2021-2032) Figure 34. Global PECAM-1 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global PECAM-1 Antibody Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global PECAM-1 Antibody Revenue Market Share by Application (2021-2032) Figure 37. Global PECAM-1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 38. Global PECAM-1 Antibody Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global PECAM-1 Antibody Sales Market Share by Application (2021-2032) Figure 40. North America PECAM-1 Antibody Revenue Share by Type (2021-2032) Figure 41. North America PECAM-1 Antibody Sales Share by Type (2021-2032) Figure 42. North America PECAM-1 Antibody Revenue Share by Application (2021-2032) Figure 43. North America PECAM-1 Antibody Sales Share by Application (2021-2032) Figure 44. North America PECAM-1 Antibody Revenue Share by Country (2021-2032) Figure 45. North America PECAM-1 Antibody Sales Share by Country (2021-2032) Figure 46. Europe PECAM-1 Antibody Revenue Share by Type (2021-2032) Figure 47. Europe PECAM-1 Antibody Sales Share by Type (2021-2032) Figure 48. Europe PECAM-1 Antibody Revenue Share by Application (2021-2032) Figure 49. Europe PECAM-1 Antibody Sales Share by Application (2021-2032) Figure 50. Europe PECAM-1 Antibody Revenue Share by Country (2021-2032) Figure 51. Europe PECAM-1 Antibody Sales Share by Country (2021-2032) Figure 52. China PECAM-1 Antibody Revenue Share by Type (2021-2032) Figure 53. China PECAM-1 Antibody Sales Share by Type (2021-2032) Figure 54. China PECAM-1 Antibody Revenue Share by Application (2021-2032) Figure 55. China PECAM-1 Antibody Sales Share by Application (2021-2032) Figure 56. Asia PECAM-1 Antibody Revenue Share by Type (2021-2032) Figure 57. Asia PECAM-1 Antibody Sales Share by Type (2021-2032) Figure 58. Asia PECAM-1 Antibody Revenue Share by Application (2021-2032) Figure 59. Asia PECAM-1 Antibody Sales Share by Application (2021-2032) Figure 60. Asia PECAM-1 Antibody Revenue Share by Country (2021-2032) Figure 61. Asia PECAM-1 Antibody Sales Share by Country (2021-2032) Figure 62. SAMEA PECAM-1 Antibody Revenue Share by Type (2021-2032) Figure 63. SAMEA PECAM-1 Antibody Sales Share by Type (2021-2032) Figure 64. SAMEA PECAM-1 Antibody Revenue Share by Application (2021-2032) Figure 65. SAMEA PECAM-1 Antibody Sales Share by Application (2021-2032) Figure 66. SAMEA PECAM-1 Antibody Revenue Share by Country (2021-2032) Figure 67. SAMEA PECAM-1 Antibody Sales Share by Country (2021-2032) Figure 68. PECAM-1 Antibody Value Chain Figure 69. Manufacturing Cost Structure Figure 70. PECAM-1 Antibody Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Mouse
  • Rabbit
  • Others
Applications
  • Laboratory
  • Hospital
  • Others
Companies covered
  • Thermo Fisher
  • YO Proteins
  • US Biological
  • SICGEN
  • Santa Cruz Biotechnology
  • Rockland Immunochemicals
  • R&D Systems
  • Proteintech Group
  • OriGene
  • Novus Biologicals
  • Miltenyi Biotec
  • MilliporeSigma
  • LifeSpan Biosciences
  • Enzo Life Sciences
  • Dianova
  • Creative Biomart
  • Boster
  • Bon Opus Biosciences
  • Bio-Rad
  • BioLegend
  • Abnova
  • Abeomics
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 PECAM-1 Antibody Market by Type
  3. 1.2.1 Global PECAM-1 Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Mouse
  5. 1.2.3 Rabbit
  6. 1.2.4 Others
  7. 1.3 PECAM-1 Antibody Market by Application
  8. 1.3.1 Global PECAM-1 Antibody Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Laboratory
  10. 1.3.3 Hospital
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 PECAM-1 Antibody Market Dynamics
  1. 2.1 PECAM-1 Antibody Industry Trends
  2. 2.2 PECAM-1 Antibody Industry Drivers
  3. 2.3 PECAM-1 Antibody Industry Opportunities and Challenges
  4. 2.4 PECAM-1 Antibody Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global PECAM-1 Antibody Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global PECAM-1 Antibody Revenue by Region
  3. 3.2.1 Global PECAM-1 Antibody Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global PECAM-1 Antibody Revenue by Region (2021-2026)
  5. 3.2.3 Global PECAM-1 Antibody Revenue by Region (2027-2032)
  6. 3.2.4 Global PECAM-1 Antibody Revenue Market Share by Region (2021-2032)
  7. 3.3 Global PECAM-1 Antibody Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global PECAM-1 Antibody Sales by Region
  9. 3.4.1 Global PECAM-1 Antibody Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global PECAM-1 Antibody Sales by Region (2021-2026)
  11. 3.4.3 Global PECAM-1 Antibody Sales by Region (2027-2032)
  12. 3.4.4 Global PECAM-1 Antibody Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global PECAM-1 Antibody Revenue by Manufacturers
  2. 4.1.1 Global PECAM-1 Antibody Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global PECAM-1 Antibody Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global PECAM-1 Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global PECAM-1 Antibody Sales by Manufacturers
  6. 4.2.1 Global PECAM-1 Antibody Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global PECAM-1 Antibody Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global PECAM-1 Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global PECAM-1 Antibody Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global PECAM-1 Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global PECAM-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global PECAM-1 Antibody Manufacturers, Product Type & Application
  13. 4.7 Global PECAM-1 Antibody Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global PECAM-1 Antibody Market CR5 and HHI
  16. 4.8.2 2025 PECAM-1 Antibody Tier 1, Tier 2, and Tier 3
5 PECAM-1 Antibody Market by Type
  1. 5.1 Global PECAM-1 Antibody Revenue by Type
  2. 5.1.1 Global PECAM-1 Antibody Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global PECAM-1 Antibody Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global PECAM-1 Antibody Revenue Market Share by Type (2021-2032)
  5. 5.2 Global PECAM-1 Antibody Sales by Type
  6. 5.2.1 Global PECAM-1 Antibody Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PECAM-1 Antibody Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global PECAM-1 Antibody Sales Market Share by Type (2021-2032)
  9. 5.3 Global PECAM-1 Antibody Price by Type
6 PECAM-1 Antibody Market by Application
  1. 6.1 Global PECAM-1 Antibody Revenue by Application
  2. 6.1.1 Global PECAM-1 Antibody Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global PECAM-1 Antibody Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global PECAM-1 Antibody Revenue Market Share by Application (2021-2032)
  5. 6.2 Global PECAM-1 Antibody Sales by Application
  6. 6.2.1 Global PECAM-1 Antibody Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global PECAM-1 Antibody Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global PECAM-1 Antibody Sales Market Share by Application (2021-2032)
  9. 6.3 Global PECAM-1 Antibody Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher
  2. 7.1.1 Thermo Fisher Company Information
  3. 7.1.2 Thermo Fisher Business Overview
  4. 7.1.3 Thermo Fisher PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher PECAM-1 Antibody Product Portfolio
  6. 7.1.5 Thermo Fisher Recent Developments
  7. 7.2 YO Proteins
  8. 7.2.1 YO Proteins Company Information
  9. 7.2.2 YO Proteins Business Overview
  10. 7.2.3 YO Proteins PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 YO Proteins PECAM-1 Antibody Product Portfolio
  12. 7.2.5 YO Proteins Recent Developments
  13. 7.3 US Biological
  14. 7.3.1 US Biological Company Information
  15. 7.3.2 US Biological Business Overview
  16. 7.3.3 US Biological PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 US Biological PECAM-1 Antibody Product Portfolio
  18. 7.3.5 US Biological Recent Developments
  19. 7.4 SICGEN
  20. 7.4.1 SICGEN Company Information
  21. 7.4.2 SICGEN Business Overview
  22. 7.4.3 SICGEN PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 SICGEN PECAM-1 Antibody Product Portfolio
  24. 7.4.5 SICGEN Recent Developments
  25. 7.5 Santa Cruz Biotechnology
  26. 7.5.1 Santa Cruz Biotechnology Company Information
  27. 7.5.2 Santa Cruz Biotechnology Business Overview
  28. 7.5.3 Santa Cruz Biotechnology PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Santa Cruz Biotechnology PECAM-1 Antibody Product Portfolio
  30. 7.5.5 Santa Cruz Biotechnology Recent Developments
  31. 7.6 Rockland Immunochemicals
  32. 7.6.1 Rockland Immunochemicals Company Information
  33. 7.6.2 Rockland Immunochemicals Business Overview
  34. 7.6.3 Rockland Immunochemicals PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Rockland Immunochemicals PECAM-1 Antibody Product Portfolio
  36. 7.6.5 Rockland Immunochemicals Recent Developments
  37. 7.7 R&D Systems
  38. 7.7.1 R&D Systems Company Information
  39. 7.7.2 R&D Systems Business Overview
  40. 7.7.3 R&D Systems PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 R&D Systems PECAM-1 Antibody Product Portfolio
  42. 7.7.5 R&D Systems Recent Developments
  43. 7.8 Proteintech Group
  44. 7.8.1 Proteintech Group Company Information
  45. 7.8.2 Proteintech Group Business Overview
  46. 7.8.3 Proteintech Group PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Proteintech Group PECAM-1 Antibody Product Portfolio
  48. 7.8.5 Proteintech Group Recent Developments
  49. 7.9 OriGene
  50. 7.9.1 OriGene Company Information
  51. 7.9.2 OriGene Business Overview
  52. 7.9.3 OriGene PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 OriGene PECAM-1 Antibody Product Portfolio
  54. 7.9.5 OriGene Recent Developments
  55. 7.10 Novus Biologicals
  56. 7.10.1 Novus Biologicals Company Information
  57. 7.10.2 Novus Biologicals Business Overview
  58. 7.10.3 Novus Biologicals PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novus Biologicals PECAM-1 Antibody Product Portfolio
  60. 7.10.5 Novus Biologicals Recent Developments
  61. 7.11 Miltenyi Biotec
  62. 7.11.1 Miltenyi Biotec Company Information
  63. 7.11.2 Miltenyi Biotec Business Overview
  64. 7.11.3 Miltenyi Biotec PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Miltenyi Biotec PECAM-1 Antibody Product Portfolio
  66. 7.11.5 Miltenyi Biotec Recent Developments
  67. 7.12 MilliporeSigma
  68. 7.12.1 MilliporeSigma Company Information
  69. 7.12.2 MilliporeSigma Business Overview
  70. 7.12.3 MilliporeSigma PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 MilliporeSigma PECAM-1 Antibody Product Portfolio
  72. 7.12.5 MilliporeSigma Recent Developments
  73. 7.13 LifeSpan Biosciences
  74. 7.13.1 LifeSpan Biosciences Company Information
  75. 7.13.2 LifeSpan Biosciences Business Overview
  76. 7.13.3 LifeSpan Biosciences PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 LifeSpan Biosciences PECAM-1 Antibody Product Portfolio
  78. 7.13.5 LifeSpan Biosciences Recent Developments
  79. 7.14 Enzo Life Sciences
  80. 7.14.1 Enzo Life Sciences Company Information
  81. 7.14.2 Enzo Life Sciences Business Overview
  82. 7.14.3 Enzo Life Sciences PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Enzo Life Sciences PECAM-1 Antibody Product Portfolio
  84. 7.14.5 Enzo Life Sciences Recent Developments
  85. 7.15 Dianova
  86. 7.15.1 Dianova Company Information
  87. 7.15.2 Dianova Business Overview
  88. 7.15.3 Dianova PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Dianova PECAM-1 Antibody Product Portfolio
  90. 7.15.5 Dianova Recent Developments
  91. 7.16 Creative Biomart
  92. 7.16.1 Creative Biomart Company Information
  93. 7.16.2 Creative Biomart Business Overview
  94. 7.16.3 Creative Biomart PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Creative Biomart PECAM-1 Antibody Product Portfolio
  96. 7.16.5 Creative Biomart Recent Developments
  97. 7.17 Boster
  98. 7.17.1 Boster Company Information
  99. 7.17.2 Boster Business Overview
  100. 7.17.3 Boster PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Boster PECAM-1 Antibody Product Portfolio
  102. 7.17.5 Boster Recent Developments
  103. 7.18 Bon Opus Biosciences
  104. 7.18.1 Bon Opus Biosciences Company Information
  105. 7.18.2 Bon Opus Biosciences Business Overview
  106. 7.18.3 Bon Opus Biosciences PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bon Opus Biosciences PECAM-1 Antibody Product Portfolio
  108. 7.18.5 Bon Opus Biosciences Recent Developments
  109. 7.19 Bio-Rad
  110. 7.19.1 Bio-Rad Company Information
  111. 7.19.2 Bio-Rad Business Overview
  112. 7.19.3 Bio-Rad PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Bio-Rad PECAM-1 Antibody Product Portfolio
  114. 7.19.5 Bio-Rad Recent Developments
  115. 7.20 BioLegend
  116. 7.20.1 BioLegend Company Information
  117. 7.20.2 BioLegend Business Overview
  118. 7.20.3 BioLegend PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 BioLegend PECAM-1 Antibody Product Portfolio
  120. 7.20.5 BioLegend Recent Developments
  121. 7.21 Abnova
  122. 7.21.1 Abnova Company Information
  123. 7.21.2 Abnova Business Overview
  124. 7.21.3 Abnova PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Abnova PECAM-1 Antibody Product Portfolio
  126. 7.21.5 Abnova Recent Developments
  127. 7.22 Abeomics
  128. 7.22.1 Abeomics Company Information
  129. 7.22.2 Abeomics Business Overview
  130. 7.22.3 Abeomics PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Abeomics PECAM-1 Antibody Product Portfolio
  132. 7.22.5 Abeomics Recent Developments
  133. 7.23 Abcam
  134. 7.23.1 Abcam Company Information
  135. 7.23.2 Abcam Business Overview
  136. 7.23.3 Abcam PECAM-1 Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Abcam PECAM-1 Antibody Product Portfolio
  138. 7.23.5 Abcam Recent Developments
8 North America
  1. 8.1 North America PECAM-1 Antibody Market Size by Type
  2. 8.1.1 North America PECAM-1 Antibody Revenue by Type (2021-2032)
  3. 8.1.2 North America PECAM-1 Antibody Sales by Type (2021-2032)
  4. 8.1.3 North America PECAM-1 Antibody Price by Type (2021-2032)
  5. 8.2 North America PECAM-1 Antibody Market Size by Application
  6. 8.2.1 North America PECAM-1 Antibody Revenue by Application (2021-2032)
  7. 8.2.2 North America PECAM-1 Antibody Sales by Application (2021-2032)
  8. 8.2.3 North America PECAM-1 Antibody Price by Application (2021-2032)
  9. 8.3 North America PECAM-1 Antibody Market Size by Country
  10. 8.3.1 North America PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America PECAM-1 Antibody Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe PECAM-1 Antibody Market Size by Type
  2. 9.1.1 Europe PECAM-1 Antibody Revenue by Type (2021-2032)
  3. 9.1.2 Europe PECAM-1 Antibody Sales by Type (2021-2032)
  4. 9.1.3 Europe PECAM-1 Antibody Price by Type (2021-2032)
  5. 9.2 Europe PECAM-1 Antibody Market Size by Application
  6. 9.2.1 Europe PECAM-1 Antibody Revenue by Application (2021-2032)
  7. 9.2.2 Europe PECAM-1 Antibody Sales by Application (2021-2032)
  8. 9.2.3 Europe PECAM-1 Antibody Price by Application (2021-2032)
  9. 9.3 Europe PECAM-1 Antibody Market Size by Country
  10. 9.3.1 Europe PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe PECAM-1 Antibody Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China PECAM-1 Antibody Market Size by Type
  2. 10.1.1 China PECAM-1 Antibody Revenue by Type (2021-2032)
  3. 10.1.2 China PECAM-1 Antibody Sales by Type (2021-2032)
  4. 10.1.3 China PECAM-1 Antibody Price by Type (2021-2032)
  5. 10.2 China PECAM-1 Antibody Market Size by Application
  6. 10.2.1 China PECAM-1 Antibody Revenue by Application (2021-2032)
  7. 10.2.2 China PECAM-1 Antibody Sales by Application (2021-2032)
  8. 10.2.3 China PECAM-1 Antibody Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia PECAM-1 Antibody Market Size by Type
  2. 11.1.1 Asia PECAM-1 Antibody Revenue by Type (2021-2032)
  3. 11.1.2 Asia PECAM-1 Antibody Sales by Type (2021-2032)
  4. 11.1.3 Asia PECAM-1 Antibody Price by Type (2021-2032)
  5. 11.2 Asia PECAM-1 Antibody Market Size by Application
  6. 11.2.1 Asia PECAM-1 Antibody Revenue by Application (2021-2032)
  7. 11.2.2 Asia PECAM-1 Antibody Sales by Application (2021-2032)
  8. 11.2.3 Asia PECAM-1 Antibody Price by Application (2021-2032)
  9. 11.3 Asia PECAM-1 Antibody Market Size by Country
  10. 11.3.1 Asia PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia PECAM-1 Antibody Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA PECAM-1 Antibody Market Size by Type
  2. 12.1.1 SAMEA PECAM-1 Antibody Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA PECAM-1 Antibody Sales by Type (2021-2032)
  4. 12.1.3 SAMEA PECAM-1 Antibody Price by Type (2021-2032)
  5. 12.2 SAMEA PECAM-1 Antibody Market Size by Application
  6. 12.2.1 SAMEA PECAM-1 Antibody Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA PECAM-1 Antibody Sales by Application (2021-2032)
  8. 12.2.3 SAMEA PECAM-1 Antibody Price by Application (2021-2032)
  9. 12.3 SAMEA PECAM-1 Antibody Market Size by Country
  10. 12.3.1 SAMEA PECAM-1 Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA PECAM-1 Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA PECAM-1 Antibody Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 PECAM-1 Antibody Value Chain Analysis
  2. 13.1.1 PECAM-1 Antibody Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 PECAM-1 Antibody Production Mode & Process
  6. 13.2 PECAM-1 Antibody Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 PECAM-1 Antibody Distributors
  9. 13.2.3 PECAM-1 Antibody Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst